ClinicalTrials.Veeva

Menu

Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Unknown

Conditions

Cardiomyopathy
Diabetic

Treatments

Other: NUCLEAR MAGNETIC RESONANCE IMAGING

Study type

Interventional

Funder types

Other

Identifiers

NCT01295385
2010-A00233-36
2009-41

Details and patient eligibility

About

Diagnosis of diabetic cardiomyopathy is then retained, supposing a change in the coronary microcirculation linked to an endothelial dysfunction. Abnormalities of the myocardial metabolism is frequently associated. It is regrettably about a hypothesis difficult to verify with current medical techniques.This deficiency being not only harmful to the diagnosis, but also to the assessment of the efficiency of the medical treatment on the myocardial metabolism and the endothelial function. Techniques of nuclear magnetic resonance offer interesting perspectives.

Full description

These techniques allow in this context:

  1. to quantify the myocardial blood flow at rest and after "cold pressor test" in a population of healthy volunteers. The myocardial blood flow will be obtained by estimating myocardial blood flow at the venous coronary sinus site. This allows us to quantify a possible endothelial dysfunction in a reproducible way. No MRI study in diabetic patients has ever been led until now with this technique.

  2. to estimate the metabolic and structural abnormalities in this population, with particularly:

    • Quantification of the myocardial metabolism in vivo by spectrometry of phosphorus 31.
    • Structural abnormalities: become integrated into the description of diabetic cardiomyopathy.

Enrollment

25 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • more than 18 years old
  • patient type 2 diabetes affects taken care more than 5 years to Timone Hospital
  • patient with a diabetic cardiomyopathy
  • informed and consented

Exclusion criteria

  • less than 18 years
  • Pregnant woman
  • patient type 1 diabetes affects
  • patient presents a cardiomyopathy mixed (no diabetic)
  • patients presents an arrhythmia ventriculaire or above - ventriculaire
  • Unstable hémodynamique patients

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

25 participants in 2 patient groups

healthy volunteers
Experimental group
Treatment:
Other: NUCLEAR MAGNETIC RESONANCE IMAGING
Other: NUCLEAR MAGNETIC RESONANCE IMAGING
patients with a diabetic cardiomyopathy
Active Comparator group
Treatment:
Other: NUCLEAR MAGNETIC RESONANCE IMAGING
Other: NUCLEAR MAGNETIC RESONANCE IMAGING

Trial contacts and locations

1

Loading...

Central trial contact

Jacques Quilici, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems